Showing all 6 results
Lithium Carbonate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Lithium Carbonate USP/Ph.Eur. 300 mg (IR) Acute Mania Standard: Immediate-release base unit used for the rapid, aggressive titration of serum lithium levels during an active, severe manic episode. Lithium Carbonate USP/Ph.Eur. 400 mg / 450 mg (ER/SR) Global Maintenance Standard: Extended-release therapy designed to flatten the pharmacokinetic curve, preventing toxic blood spikes and minimizing severe hand tremors and nausea during lifelong maintenance therapy. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate / Premium Opadry Film Hydrophilic ER Polymer / Diluent / Disintegrant / Lubricant (Engineered specifically using high-shear wet granulation to form a highly reliable, slow-eroding matrix that trickles the elemental lithium into the bloodstream over 12 hours) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict, massive-volume lifelong psychiatric dispensing regimens).
Mirtazapine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the tetracyclic compound.
Active Ingredient Strength Primary Clinical Function Mirtazapine Ph.Eur./USP 15 mg Initiation / Maximum Sedation Standard: Base unit. (Clinical Quirk: Due to histamine saturation, the 15mg dose is actually MORE sedating than the higher doses, making it the primary choice for severe insomnia.) Mirtazapine Ph.Eur./USP 30 mg / 45 mg Global Psychiatry Standard: High-efficacy adult maintenance therapy for severe Major Depressive Disorder (MDD). At these doses, increased norepinephrine release counteracts some of the histamine-induced sedation. Excipients Microcrystalline Cellulose / Crospovidone / Mannitol / Aspartame / Magnesium Stearate / Premium Flavoring Diluent / Superdisintegrant / Sweetening Agent / Lubricant (Engineered specifically for rapid gastric or sublingual dissolution, heavily utilizing artificial sweeteners and flavors to completely mask the intensely bitter API for geriatric compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic psychiatric dispensing regimens).
Nitrazepam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient and prevent unauthorized access.
Active Ingredient Strength Primary Clinical Function Nitrazepam BP/Ph.Eur. 5 mg Initiation / Elderly Standard: Base therapeutic unit for the short-term management of severe insomnia, specifically titrated for elderly patients to prevent next-day falls. Nitrazepam BP/Ph.Eur. 10 mg Severe Psychiatric Standard: Maximum adult dose to force sleep in highly agitated, refractory, or acutely manic patients. Excipients Lactose Monohydrate / Maize Starch / Microcrystalline Cellulose / Magnesium Stearate / Colloidal Silicon Dioxide Diluent / Binder / Disintegrant / Lubricant (Engineered specifically for rapid gastric dissolution, inducing sleep within 30 to 60 minutes of ingestion) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 2-to-4 week acute psychiatric dispensing regimens to prevent dependency).
Olanzapine & Fluoxetine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Capsule or Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly oxidative Olanzapine molecule.
Active Ingredient Strength Primary Clinical Function Olanzapine Ph.Eur./USP 3 mg / 6 mg / 12 mg Atypical Base: Modulates 5-HT2A/D2 receptors to stabilize severe mood swings and trigger prefrontal synergy. Fluoxetine (as HCl) Ph.Eur./USP 25 mg / 50 mg SSRI Driver: Forces a massive serotonin pool in the synaptic cleft to elevate refractory depressive lows. Excipients Pregelatinized Starch / Croscarmellose Sodium / Microcrystalline Cellulose / Magnesium Stearate / Opadry Film Moisture-Scavenging Diluent / Superdisintegrant / Binder / Premium Oxygen-Barrier Film-Coating (Engineered specifically to physically isolate the highly sensitive Olanzapine from cross-reacting with Fluoxetine) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic psychiatric dispensing regimens).
Paroxetine Tablets (CR)
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the extended-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 12.5 mg (CR) Initiation Standard: Base titration unit to safely acclimatize the brain and minimize initial side effects. Gold standard for PMDD. Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 25 mg (CR) Global Clinical Standard: Standard adult maintenance dose for Major Depressive Disorder and Severe Panic Disorder. Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 37.5 mg (CR) Advanced Psychiatric Standard: High-dose maintenance therapy for treatment-resistant depression and refractory anxiety. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Lactose Monohydrate / Magnesium Stearate / Triethyl Citrate Hydrophilic SR Polymer Matrix / Enteric Coating / Diluent / Plasticizer (Engineered to absolutely block stomach acid and control the exact 24-hour intestinal diffusion rate) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic psychiatric dispensing regimens).
Procyclidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Procyclidine HCl BP/Ph.Eur. 5 mg Global Clinical Standard: Base therapeutic unit for the rapid reversal of EPS and parkinsonian rigidity. Excipients Lactose Monohydrate / Sodium Starch Glycolate / Povidone / Magnesium Stearate Diluent / Superdisintegrant / Binder / Lubricant (Engineered for rapid gastric dissolution and ultra-fast crossing of the blood-brain barrier) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-volume daily dispensing in acute psychiatric and neurology wards).
